These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16078853)

  • 21. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex.
    Fredenburgh JC; Stafford AR; Leslie BA; Weitz JI
    J Biol Chem; 2008 Feb; 283(5):2470-7. PubMed ID: 18055456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin.
    Rezaie AR
    Protein Sci; 1998 Feb; 7(2):349-57. PubMed ID: 9521111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
    Mourier PA; Guichard OY; Herman F; Viskov C
    Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different.
    Mosier PD; Krishnasamy C; Kellogg GE; Desai UR
    PLoS One; 2012; 7(11):e48632. PubMed ID: 23152789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of inhibition rate enhancement by covalent linkage of antithrombin to heparin as a potential predictor of reaction mechanism.
    Patel S; Berry LR; Chan AK
    J Biochem; 2007 Jan; 141(1):25-35. PubMed ID: 17167048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects.
    Olson ST; Björk I
    J Biol Chem; 1991 Apr; 266(10):6353-64. PubMed ID: 2007588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
    Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
    J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.
    Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I
    J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the heparin-binding domain of antithrombin.
    Wu YI; Sheffield WP; Blajchman MA
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):83-95. PubMed ID: 8180343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydropathic interaction analyses of small organic activators binding to antithrombin.
    Gunnarsson GT; Desai UR
    Bioorg Med Chem; 2004 Feb; 12(3):633-40. PubMed ID: 14738974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
    Schedin-Weiss S; Richard B; Hjelm R; Olson ST
    Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanisms of action of alpha- and beta-isoforms of antithrombin.
    Swedenborg J
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S7-10. PubMed ID: 10102493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
    Peterson CB; Morgan WT; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.
    Schedin-Weiss S; Richard B; Olson ST
    Arch Biochem Biophys; 2010 Dec; 504(2):169-76. PubMed ID: 20816747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin.
    Langdown J; Belzar KJ; Savory WJ; Baglin TP; Huntington JA
    J Mol Biol; 2009 Mar; 386(5):1278-89. PubMed ID: 19452598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101.
    Ye J; Rezaie AR; Esmon CT
    J Biol Chem; 1994 Jul; 269(27):17965-70. PubMed ID: 8027055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.